US FDA Staff--Schering-Plough Corporation (JOBS) Antipsychotic Works

Reuters - Schering-Plough Corp's (SGP.N) experimental antipsychotic drug Saphris works and appears as safe as other similar medications, U.S. Food and Drug Administration staff said in a memo released on Tuesday.